These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7677031)
1. Effect of disk maturation on diffusion of low-molecular-weight gadolinium complexes: an experimental study in rabbits. Ibrahim MA; Haughton VM; Hyde JS AJNR Am J Neuroradiol; 1995; 16(6):1307-11. PubMed ID: 7677031 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of intervertebral disks with gadolinium complexes: comparison of an ionic and a nonionic medium in an animal model. Ibrahim MA; Haughton VM; Hyde JS AJNR Am J Neuroradiol; 1994 Nov; 15(10):1907-10. PubMed ID: 7863940 [TBL] [Abstract][Full Text] [Related]
3. Contrast enhancement of normal intervertebral disks: time and dose dependence. Ibrahim MA; Jesmanowicz A; Hyde JS; Estkowski L; Haughton VM AJNR Am J Neuroradiol; 1994 Mar; 15(3):419-23. PubMed ID: 8197936 [TBL] [Abstract][Full Text] [Related]
4. Diffusion into human intervertebral disks studied with MR and gadoteridol. Akansel G; Haughton VM; Papke RA; Censky S AJNR Am J Neuroradiol; 1997 Mar; 18(3):443-5. PubMed ID: 9090400 [TBL] [Abstract][Full Text] [Related]
5. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Tweedle MF; Wedeking P; Kumar K Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190 [TBL] [Abstract][Full Text] [Related]
6. Utility of high-dose contrast enhancement for detecting recurrent herniated intervertebral disks. Nguyen C; An H; Ho KC; Haughton VM; Hasegawa T AJNR Am J Neuroradiol; 1994 Aug; 15(7):1291-7. PubMed ID: 7976941 [TBL] [Abstract][Full Text] [Related]
7. Effect of degeneration of the intervertebral disk on the process of diffusion. Nguyen-minh C; Riley L; Ho KC; Xu R; An H; Haughton VM AJNR Am J Neuroradiol; 1997 Mar; 18(3):435-42. PubMed ID: 9090399 [TBL] [Abstract][Full Text] [Related]
8. An experimental model to study contrast enhancement in MR imaging of the intervertebral disk. Nguyen CM; Ho KC; Yu SW; Haughton VM; Strandt JA AJNR Am J Neuroradiol; 1989; 10(4):811-4. PubMed ID: 2505508 [TBL] [Abstract][Full Text] [Related]
9. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging. Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081 [TBL] [Abstract][Full Text] [Related]
10. Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions: A Comparative Animal Study. Knobloch G; Frenzel T; Pietsch H; Jost G Invest Radiol; 2020 Jun; 55(6):367-373. PubMed ID: 31985602 [TBL] [Abstract][Full Text] [Related]
12. Measuring diffusion of solutes into intervertebral disks with MR imaging and paramagnetic contrast medium. Nguyen-minh C; Haughton VM; Papke RA; An H; Censky SC AJNR Am J Neuroradiol; 1998 Oct; 19(9):1781-4. PubMed ID: 9802505 [TBL] [Abstract][Full Text] [Related]
13. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501 [TBL] [Abstract][Full Text] [Related]
14. Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence. Kuperman VY; Karczmar GS; Blomley MJ; Lewis MZ; Lubich LM; Lipton MJ J Magn Reson Imaging; 1996; 6(5):764-8. PubMed ID: 8890014 [TBL] [Abstract][Full Text] [Related]
15. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging. Lauffer RB; Parmelee DJ; Ouellet HS; Dolan RP; Sajiki H; Scott DM; Bernard PJ; Buchanan EM; Ong KY; Tyeklár Z; Midelfort KS; McMurry TJ; Walovitch RC Acad Radiol; 1996 Aug; 3 Suppl 2():S356-8. PubMed ID: 8796603 [No Abstract] [Full Text] [Related]
16. Dynamic MRI of a hypovascularized liver tumor model: comparison of a new blood pool contrast agent (24-gadolinium-DTPA-cascade-polymer) with gadopentetate dimeglumine. Tacke J; Adam G; Classen H; Mühler A; Prescher A; Günther RW J Magn Reson Imaging; 1997; 7(4):678-82. PubMed ID: 9243388 [TBL] [Abstract][Full Text] [Related]
17. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657 [TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of contrast media for magnetic resonance imaging after generalized breakdown of the blood-brain barrier. Evill CA; Wilson AJ; Fletcher MC; Sage MR Acad Radiol; 1996 Aug; 3 Suppl 2():S336-8. PubMed ID: 8796597 [No Abstract] [Full Text] [Related]
19. Gadopentetate dimeglumine clearance in renal insufficiency in rabbits. Frank JA; Choyke PL; Girton ME; Morrison P; Diggs R; Skinner M Invest Radiol; 1990 Nov; 25(11):1212-6. PubMed ID: 2254055 [TBL] [Abstract][Full Text] [Related]
20. First-pass perfusion measurements of the rat and human brain: experimental data and first clinical observations. Laubenberger J; Hennig J; Blick S; Strohschein R; Langer M Acad Radiol; 1996 Aug; 3 Suppl 2():S387-8. PubMed ID: 8796610 [No Abstract] [Full Text] [Related] [Next] [New Search]